lookindex

Epitalon

Also known as Epithalon, AEDG peptide

Sold as a telomere-lengthening anti-ageing peptide. The lab findings are real but early, and the dramatic human results come from a single group without independent trials.

Information only. Not medical advice. Talk to a doctor before you start, stop or change anything.

What people claim

  • Lengthens telomeres
  • Slows ageing and improves skin
  • Extends lifespan

What the evidence shows

  • It raised telomerase activity and telomere length in human cell cultures, including in a 2025 study by researchers outside the original group.[1][2]
  • A 2026 review says cell findings should not be read as proof that it improves health or extends human life, and that independent replication remains limited.[2]
  • We found no controlled trial of skin or appearance.[2]

Known risks

  • Telomerase is switched back on in most human cancers. Whether boosting it in people raises cancer risk has not been studied.[1]
  • FDA has no safety information for the proposed route and flags immune reactions and impurities.[3]

Reported side effects

Moderated user reports are not open yet, so nothing is shown here. They will be labelled as unverified personal accounts.

Legal status

A summary, not legal advice. Rules change, and sport bans are separate.

United States

Unapproved, compounding tolerated

Included in the October 2026 HHS interim policy for injectable compounding on a patient-specific prescription. It is not FDA approval, and "research use" products are not covered.[4]

United Kingdom

Unlicensed

No licensed medicine contains it.

Australia

Not approved

TGA says importing, advertising or supplying unapproved peptides is unlawful.[5]

European Union

Not authorised

No authorised medicine. National rules on possession and import differ.

Sources

  1. 1.Epitalon increases telomere length in human cell linesIndependent cell study, 2025
  2. 2.Epitalon and epithalamin: a narrative review of mechanistic, preclinical and clinical evidenceInternational Journal of Molecular Sciences, 2026
  3. 3.Bulk drug substances that may present significant safety risksUS FDA
  4. 4.HHS interim enforcement discretion policy for six peptides (legal summary)Holland & Knight, Nov 2026
  5. 5.Importing, compounding and supplying unapproved peptide productsTGA Australia

Profile last checked 7 Nov 2026.